The current stock price of MZOR is 58.23 null. In the past month the price decreased by -0.12%. In the past year, price increased by 7.79%.
ChartMill assigns a technical rating of 5 / 10 to MZOR. When comparing the yearly performance of all stocks, MZOR is one of the better performing stocks in the market, outperforming 90% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MZOR. While MZOR has a great health rating, there are worries on its profitability.
Over the last trailing twelve months MZOR reported a non-GAAP Earnings per Share(EPS) of -0.30000000000000004. The EPS increased by 57.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -36.9% | ||
| ROA | -16.19% | ||
| ROE | -19.62% | ||
| Debt/Equity | 0 |
Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel.
Mazor Robotics Ltd.
5 SHACHAM STREET NORTH INDUSTRIAL PARK
CAESAREA L3 3088900
CEO: Ori Hadomi
Phone: 972-4618-7101
Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel.
The current stock price of MZOR is 58.23 null. The price decreased by -0.05% in the last trading session.
MZOR does not pay a dividend.
MZOR has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.